Pulmatrix (PULM) Current Deferred Revenue (2019 - 2024)
Pulmatrix's Current Deferred Revenue was $270,000 in Q2 2024, down 75.7% from $1.11 million a year earlier and down 25.6% from the prior quarter.
Powered by 
Analysis
Pulmatrix (PULM) Current Deferred Revenue (2019 - 2024) Analysis & Trends
At the end of FY2023, Current Deferred Revenue at Pulmatrix came in at $618,000, down 53.8% from FY2022.
- Current Deferred Revenue shows a four-year compound annual growth rate of -53.7% (FY2019 to FY2023).
- In earlier years, Current Deferred Revenue was $1.34 million in FY2022 (+42.6%), $939,000 in FY2021 (-77.5%), $4.17 million in FY2020 (-68.9%) and $13.41 million in FY2019.
- The Q2 2024 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q2 2019.
- Compared with a year earlier, Current Deferred Revenue has declined for five straight quarters, with an average decline of 29.7% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2022 (growth of 42.6%); the worst was Q1 2024 (a decline of 78.8%).
- Per Business Quant data, PULM's Current Deferred Revenue in the three quarters before Q2 2024 was $363,000 (Q1 2024), $618,000 (Q4 2023) and $988,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Pulmatrix | 5.81 Mn | -8.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 270,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Dec 31, 2023 | 618,000.00 |
| Sep 30, 2023 | 988,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 939,000.00 |
| Sep 30, 2021 | 1.97 Mn |
| Jun 30, 2021 | 3.03 Mn |
| Mar 31, 2021 | 3.14 Mn |
| Dec 31, 2020 | 4.17 Mn |
| Sep 30, 2020 | 4.26 Mn |
| Jun 30, 2020 | 10.04 Mn |
| Mar 31, 2020 | 12.03 Mn |
| Dec 31, 2019 | 13.41 Mn |
| Sep 30, 2019 | 9.30 Mn |
API Access
Pulmatrix Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PULM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();